Aspr-16-06443 -- task order to lberi under rtor-radnuc-1004 a non-primate model study of host biomarker expression due to ionizing radiation exposure combined with therapeutic administration or a…
Ended Awarded Last action
- Contract number
- HHSO10033003T
- Awardee
-
Lovelace Biomedical And Environmental Research Institute, Inc. UEI N1UBCLRAPNG6 Part of Lovelace Biomedical Research Institute
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $1,764,757
Award facts
- Opportunity
-
- RFP15100SOL00004 Solicitation number
- BARDA Chem and RadNuc Animal Model Development Award Notice · Posted Dec 5, 2014
- Contract value 100% obligated
- $1,764,756.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albuquerque, NM 87108, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$83,839 | |
| Original award | $1,848,596 |
About this award
This is a $1,764,756.57 cost-plus-fixed-fee delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of Lovelace Biomedical Research Institute. The order was issued under the Biomedical Advanced Research and Development Authority (BARDA) Chem and RadNuc Animal Model 2015-2020 IDIQ contract. The purpose is to conduct a non-primate animal model study on host biomarker expression due to ionizing radiation exposure combined with therapeutic administration or a higher dose rate. LBERI has over 70 years of expertise in areas like inhalation toxicology, infectious disease modeling, and medical countermeasure testing, which it leverages to support federal agencies such as NIH, NIAID, and BARDA. This contract award does not have a set-aside designation.
Description
Aspr-16-06443 -- task order to lberi under rtor-radnuc-1004 a non-primate model study of host biomarker expression due to ionizing radiation exposure combined with therapeutic administration or a higher dose rate
Quick answers
Who was awarded contract HHSO10033003T?
HHSO10033003T was awarded to Lovelace Biomedical And Environmental Research Institute, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 30, 2016.
How much is contract HHSO10033003T worth?
The government has obligated $1,764,757 on HHSO10033003T.
Is contract HHSO10033003T an order under another contract?
Yes. HHSO10033003T is a delivery order under HHSO100201500002I, an indefinite delivery contract, on BARDA Chem and RadNuc Animal Model 2015-2020.
Was contract HHSO10033003T competed?
The extent of competition for HHSO10033003T was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award